title: Refractory IGκ/IRF4-positive DLBCL with CDKN2A/2B deletion.
authors.affiliation: Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan, kchona@kuhp.kyoto-u.ac.jp.
authors.forename: Kazuhisa
authors.initials: K
authors.lastname: Chonabayashi
authors.forename: Shigeki
authors.initials: S
authors.lastname: Tamori
authors.forename: Masafumi
authors.initials: M
authors.lastname: Taniwaki
authors.forename: Haruyuki
authors.initials: H
authors.lastname: Fujita
authors.forename: Yayoi
authors.initials: Y
authors.lastname: Shimazu
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Matsui
authors.forename: Masakatsu
authors.initials: M
authors.lastname: Hishizawa
authors.forename: Kazumasa
authors.initials: K
authors.lastname: Usami
authors.forename: Akifumi
authors.initials: A
authors.lastname: Takaori-Kondo
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D050762:Cyclin-Dependent Kinase Inhibitor p15 / Q000172:deficiency / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000172:deficiency / Q000235:genetics*; D019008:Drug Resistance, Neoplasm; D017809:Fatal Outcome; D017353:Gene Deletion; D015870:Gene Expression; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics*; D050835:Interferon Regulatory Factors / Q000235:genetics*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D000099218:Interferon Regulatory Factor-4
chemical_list: D000970:Antineoplastic Agents; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16; D007136:Immunoglobulins; D050835:Interferon Regulatory Factors; D000099218:Interferon Regulatory Factor-4; C493966:CDKN2B protein, human; C014609:IgK